Avidity Partners Management’s Repligen RGEN Stock Holding History
Bought
Maintained
Sold
Other funds holding RGEN
UCFA
VCM
VPM
MC
Avidity Partners Management's RGEN Position: Q1 2026 in Review
Avidity Partners Management increased its Repligen (RGEN) stake by 209% in Q1 2026, buying an estimated $14.7M and bringing the position to 155,600 shares worth $18.4M. The position accounts for 1.96% of the portfolio, ranked #9.
Avidity Partners Management first reported a position in RGEN in Q2 2025 and has held it in 4 quarters since. 441 funds tracked by Wall St. Rank hold RGEN as of Q1 2026.
- Avidity Partners Management held 155,600 shares of Repligen worth $18.4M as of Q1 2026.
- Avidity Partners Management bought 105,300 Repligen shares in Q1 2026, an estimated $14.7M.
- Repligen made up 1.96% of Avidity Partners Management's portfolio in Q1 2026, its #9 holding.
- Avidity Partners Management first reported a position in Repligen in Q2 2025 and has held it in 4 quarters since.
- 441 funds tracked by Wall St. Rank held Repligen as of Q1 2026.
Based on Avidity Partners Management's 13F filing for Q1 2026, filed 13 May 2026.